Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population
Author(s) -
Rulan Griesel,
Phumla Sinxadi,
Aida N. Kawuma,
John A. Joska,
Simiso Sokhela,
Godspower Akpomiemie,
François Venter,
Paolo Denti,
David W. Haas,
Gary Maartens
Publication year - 2022
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac290
Subject(s) - dolutegravir , medicine , adverse effect , pharmacokinetics , population , oncology , pharmacogenetics , pharmacology , viral load , antiretroviral therapy , virology , genetics , genotype , biology , human immunodeficiency virus (hiv) , gene , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom